About Bio-Technology General
Bio-Technology General: Pioneering Development and Manufacture of Human Health Care Products
Bio-Technology General (BTG) is a leading biopharmaceutical company that specializes in the development and manufacture of human health care products derived from genetic engineering and biotechnology processes. With a successful track record of developing and registering biopharmaceuticals, BTG has become a trusted name in the industry.
Founded in 1984, BTG has been at the forefront of innovation in the field of biotechnology. The company's mission is to improve human health by developing safe, effective, and affordable therapies for patients suffering from serious diseases. Over the years, BTG has developed a wide range of products that have helped millions of people around the world.
One of BTG's key strengths is its expertise in genetic engineering. The company uses advanced techniques to modify genes and produce proteins that can be used as therapeutic agents. This approach allows BTG to develop highly targeted treatments for specific diseases, which can be more effective than traditional drugs.
BTG's product portfolio includes a range of biopharmaceuticals for treating cancer, autoimmune disorders, infectious diseases, and other conditions. Some notable products include Neupogen®, which stimulates white blood cell production; Leukine®, which boosts immune function; and Prokine®, which promotes red blood cell production.
In addition to its core business of developing new therapies, BTG also offers contract manufacturing services to other companies in the industry. This allows smaller firms with limited resources to benefit from BTG's expertise in process development and manufacturing.
BTG operates state-of-the-art facilities that are compliant with international regulatory standards such as cGMP (current Good Manufacturing Practice). These facilities are equipped with advanced technologies such as single-use systems that minimize contamination risks while maximizing efficiency.
The company also invests heavily in research and development (R&D) activities aimed at discovering new treatments for unmet medical needs. Its R&D efforts are focused on areas such as oncology, immunology, neurology, cardiovascular disease, and rare diseases.
BTG has received numerous awards over the years for its contributions to the field of biotechnology. In 2019 alone it was awarded "Best Biotech Company" by Global Health & Pharma magazine; "Best Contract Manufacturing Organization" by European CEO magazine; "Top Innovator" by Israel Innovation Authority; among others.
In conclusion Bio-Technology General is an innovative leader within their industry who have made significant contributions towards improving human health through their pioneering developments within genetic engineering & bio technology processes resulting into registered bio pharmaceuticals . Their commitment towards research & development along with their state-of-the-art facilities makes them one step ahead when it comes down to providing quality healthcare solutions globally .